AMEX · Financial Statements
AEON Biopharma, Inc. (AEON) Financial Statements
$0.28
AMEX: AEON
Market Cap $12.19M
Overview Financials Dividend AEON Biopharma, Inc. most recently reported annual revenue of $0, net profit of $-39.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-66.0M $-48.0M $-348.0M $73.0M $-13.0M Net Profit $-56.0M $-53.0M $-385.0M $42.0M $-39.0M EPS $18.86 $-27.25 $-744.83 $72.93 $-3.95 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $6.0M $11.0M $7.0M $3.0M $6.0M Total Liabilities $230.0M $281.0M $160.0M $32.0M $61.0M Cash $5.0M $10.0M $5.0M $0 $3.0M Borrowings $87.0M $132.0M $0 $13.0M $36.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-28.0M $-36.0M $-48.0M $-20.0M $-17.0M Investing Cash Flow $0 $-1.0M $0 $0 $0 Financing Cash Flow $-1.0M $0 $0 $0 $2.0M Net Cash Flow $-15.0M $5.0M $-5.0M $-5.0M $3.0M Free Cash Flow $-29.0M $-36.0M $-48.0M $-20.0M $-17.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.51 FCF Yield -99.25% Quick Ratio 0.54 Interest Coverage 0.00 Return 1Y -62.49% Return 3Y -99.95% Return 5Y —
Screens featuring this stock